DDW 2013:肥胖儿童的VOC浓度较高

2013-05-22 佚名 EGMN

  克利夫兰儿童医院的Naim Alkhouri博士在消化疾病周(DDW)会前新闻发布会上报告了一项对照研究的结果:与非肥胖儿童相比,肥胖儿童的呼气挥发性有机物(VOC)浓度明显更高。   这一发现或许有助于我们更深入地理解指向儿童期肥胖的病理生理学过程和路径。利用这些“呼吸印迹”,我们还有可能找到新的儿童期肥胖干预手段。   针对60名肥胖儿童和55名体瘦对照儿童的质谱分析结果表明

  克利夫兰儿童医院的Naim Alkhouri博士在消化疾病周(DDW)会前新闻发布会上报告了一项对照研究的结果:与非肥胖儿童相比,肥胖儿童的呼气挥发性有机物(VOC)浓度明显更高。

  这一发现或许有助于我们更深入地理解指向儿童期肥胖的病理生理学过程和路径。利用这些“呼吸印迹”,我们还有可能找到新的儿童期肥胖干预手段。

  针对60名肥胖儿童和55名体瘦对照儿童的质谱分析结果表明,二者在超过50种VOC的浓度方面都存在差异。根据其中4种离子的峰浓度,即可识别出92%的超重/肥胖儿童。

  进一步分析显示,在校正年龄、身高和种族之后,这4种VOC的浓度仍然是肥胖儿童显著高于非肥胖儿童:呼气异戊二烯(11.6 vs. 6.2 ppb)、1-辛烯(7.7 vs. 4.6 ppb)、氨(67.4 vs. 50.1 ppb),以及硫化氢(0.49 vs. 0.35 ppb)。

  本项研究的超重和肥胖受试儿童是一家预防心脏病和代谢病的儿童医院的患者,健康对照者则是在一家综合性儿童医院接受体检的健康儿童。所有受试者均接受了单次呼气样本采集,采用的是选择性离子流量测定管-质谱分析法。肥胖组儿童的年龄(平均14.1 vs. 12.1岁)、身高(平均164.9 vs. 153.3 cm)和白人比例(60% vs. 35.2%)显著大于体瘦组儿童。

  Alkhouri博士指出:“据我们估计,17%的美国儿童属于肥胖范畴,32%属于超重。这些儿童面临较高的疾病风险,包括糖尿病、阻塞性睡眠呼吸暂停、非酒精性脂肪性肝病和心血管疾病等。我们认为,‘呼吸印迹’将有助于找出儿童期肥胖的病因和并发症,以及探索更简单易行的肥胖相关并发症筛查方法。”

Exhaled VOC concentrations provide childhood obesity clues
Concentrations of certain exhaled volatile organic compounds are significantly higher in obese children than in nonobese children, according to findings from a controlled study involving more than 100 children.
The findings could lead to improved understanding of the pathophysiologic processes and pathways leading to childhood obesity, according to Dr. Naim Alkhouri of Cleveland Clinic Children’s Hospital.
These "breath prints" also could lead to interventions for childhood obesity, Dr. Alkhouri said at a press briefing held in advance of the annual Digestive Disease Week, where the data will be presented.
Mass spectrometry in 60 obese children and 55 lean controls demonstrated differences in the concentrations of more than 50 volatile organic compounds (VOCs). Four ion peaks were shown to identify overweight/obese subjects with 92% accuracy, he said...

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1717191, encodeId=52f71e1719107, content=<a href='/topic/show?id=4b0a8189ed5' target=_blank style='color:#2F92EE;'>#肥胖儿童#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81897, encryptionId=4b0a8189ed5, topicName=肥胖儿童)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad9f32366344, createdName=minlingfeng, createdTime=Tue Apr 15 09:05:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429594, encodeId=0c1614295948a, content=<a href='/topic/show?id=97c25e83dd' target=_blank style='color:#2F92EE;'>#DDW#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5783, encryptionId=97c25e83dd, topicName=DDW)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri May 24 00:05:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544371, encodeId=c75915443e1a8, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Fri May 24 00:05:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1717191, encodeId=52f71e1719107, content=<a href='/topic/show?id=4b0a8189ed5' target=_blank style='color:#2F92EE;'>#肥胖儿童#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81897, encryptionId=4b0a8189ed5, topicName=肥胖儿童)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad9f32366344, createdName=minlingfeng, createdTime=Tue Apr 15 09:05:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429594, encodeId=0c1614295948a, content=<a href='/topic/show?id=97c25e83dd' target=_blank style='color:#2F92EE;'>#DDW#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5783, encryptionId=97c25e83dd, topicName=DDW)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri May 24 00:05:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544371, encodeId=c75915443e1a8, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Fri May 24 00:05:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]
    2013-05-24 智智灵药
  3. [GetPortalCommentsPageByObjectIdResponse(id=1717191, encodeId=52f71e1719107, content=<a href='/topic/show?id=4b0a8189ed5' target=_blank style='color:#2F92EE;'>#肥胖儿童#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81897, encryptionId=4b0a8189ed5, topicName=肥胖儿童)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad9f32366344, createdName=minlingfeng, createdTime=Tue Apr 15 09:05:00 CST 2014, time=2014-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429594, encodeId=0c1614295948a, content=<a href='/topic/show?id=97c25e83dd' target=_blank style='color:#2F92EE;'>#DDW#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5783, encryptionId=97c25e83dd, topicName=DDW)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri May 24 00:05:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1544371, encodeId=c75915443e1a8, content=<a href='/topic/show?id=ac3d6549e75' target=_blank style='color:#2F92EE;'>#浓度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65497, encryptionId=ac3d6549e75, topicName=浓度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16b213663040, createdName=12498974m55暂无昵称, createdTime=Fri May 24 00:05:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]

相关资讯

Nat. Rev. Endocrinol.: 肥胖治疗新靶点及脂肪组织的可塑性

关键进展: 在白色脂肪组织储存库中鉴定了第三种先前未确认的脂肪细胞--表达线粒体解偶联蛋白1(UCP1)的米色脂肪细胞      双潜能脂肪始祖细胞能够产生棕色和白色脂肪细胞 鉴定了一个新的激素,即鸢尾素,它能够诱导皮下白色脂肪组织中表达UCP1的米色脂肪细胞形成 2012年的脂肪细胞研究是丰收的一年。研究发现了一种新型的棕色样脂肪细胞(又叫

ECO2013:过去60年的数据显示儿时的肥胖和身高指数与成人子宫内膜癌相关

发布在5月12日开始的利维浦欧洲肥胖会议(ECO)上的一项新的研究显示儿童期的肥胖和身高指数可能与成人期子宫内膜癌相关。这项研究由哥本哈根大学附属医院预防医学研究院的Julie Aarestrup,Copenhagen, Denmark及其同事完成。欧洲每年新发子宫内膜癌超过90,000例,在女性肿瘤中排名第四。对于成年女性,子宫内膜癌的风险增加与高体质指数(BMI)密切相关,而与身高无明显相关。

PNAS:消化道细菌A. muciniphila或可用于预防肥胖

日前,比利时与荷兰的研究发现,消化道细菌Akkermansia muciniphila可能在维持消化道粘膜屏障和防止肥胖相关代谢疾病方面起到了一个关键的作用。研究人员发现,生活在消化道的营养丰富的粘液层的主要的细菌A. muciniphila的丰富程度在肥胖和II型糖尿病小鼠体内减少了。研究人员还观察到了,让这些小鼠服用低聚果糖益生元(oligofructose prebiotics)能恢复A.